MX2009002228A - Composiciones y metodos para tratar o prevenir glaucoma o el avance del mismo. - Google Patents

Composiciones y metodos para tratar o prevenir glaucoma o el avance del mismo.

Info

Publication number
MX2009002228A
MX2009002228A MX2009002228A MX2009002228A MX2009002228A MX 2009002228 A MX2009002228 A MX 2009002228A MX 2009002228 A MX2009002228 A MX 2009002228A MX 2009002228 A MX2009002228 A MX 2009002228A MX 2009002228 A MX2009002228 A MX 2009002228A
Authority
MX
Mexico
Prior art keywords
treating
progression
compositions
methods
preventing glaucoma
Prior art date
Application number
MX2009002228A
Other languages
English (en)
Inventor
Stephen P Bartels
Original Assignee
Bausch & Lomb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bausch & Lomb filed Critical Bausch & Lomb
Publication of MX2009002228A publication Critical patent/MX2009002228A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Una composición para tratar o prevenir glaucoma o su avance que comprende un agonista del receptor glucocorticoide disociado ("DIGRA"), su profármaco, su sal farmacéuticamente aceptable, o su éster farmacéuticamente aceptable. La composición puede comprender un agente anti-inflamatorio adicional y puede formularse para aplicación tópica, inyección, o implante. Se puede utilizar en combinación con otra terapia dirigida para reducir la presión intraocular.
MX2009002228A 2006-08-31 2007-08-24 Composiciones y metodos para tratar o prevenir glaucoma o el avance del mismo. MX2009002228A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84143706P 2006-08-31 2006-08-31
PCT/US2007/076706 WO2008027796A2 (en) 2006-08-31 2007-08-24 Compositions and methods for treating or preventing glaucoma or progression thereof

Publications (1)

Publication Number Publication Date
MX2009002228A true MX2009002228A (es) 2009-04-17

Family

ID=39077201

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009002228A MX2009002228A (es) 2006-08-31 2007-08-24 Composiciones y metodos para tratar o prevenir glaucoma o el avance del mismo.

Country Status (16)

Country Link
US (1) US20080058373A1 (es)
EP (2) EP2056799B1 (es)
JP (1) JP2010502635A (es)
KR (1) KR20090050091A (es)
CN (1) CN101528208A (es)
AU (1) AU2007289373A1 (es)
BR (1) BRPI0716087A2 (es)
CA (1) CA2661607C (es)
DK (1) DK2056799T3 (es)
ES (1) ES2425178T3 (es)
MX (1) MX2009002228A (es)
PL (1) PL2056799T3 (es)
PT (1) PT2056799E (es)
SI (1) SI2056799T1 (es)
TW (1) TWI336701B (es)
WO (1) WO2008027796A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090042936A1 (en) * 2007-08-10 2009-02-12 Ward Keith W Compositions and Methods for Treating or Controlling Anterior-Segment Inflammation
US20090087443A1 (en) * 2007-09-27 2009-04-02 Bartels Stephen P Pharmacological Adjunctive Treatment Associated with Glaucoma Filtration Surgery
EP2214644B1 (en) * 2007-11-05 2013-03-20 Bausch & Lomb Incorporated Water-immiscible materials as vehicles for drug delivery
US20110077270A1 (en) * 2009-04-21 2011-03-31 Pfeffer Bruce A Compositions and Methods for Treating Ocular Inflammation with Lower Risk of Increased Intraocular Pressure
RU2473363C1 (ru) * 2012-02-24 2013-01-27 Илья Александрович Марков Противовирусное средство - глазные капли
RU2561046C1 (ru) * 2014-10-30 2015-08-20 Илья Александрович Марков Гелеобразные глазные капли для лечения воспалительных, аллергических, бактериальных, вирусных, травматических и дистрофических заболеваний глаз
EP3914249A1 (en) 2019-01-22 2021-12-01 Akribes Biomedical GmbH Selective glucocorticoid receptor modifiers for treating impaired skin wound healing

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378475A (en) * 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
US6051576A (en) * 1994-01-28 2000-04-18 University Of Kentucky Research Foundation Means to achieve sustained release of synergistic drugs by conjugation
US5773019A (en) * 1995-09-27 1998-06-30 The University Of Kentucky Research Foundation Implantable controlled release device to deliver drugs directly to an internal portion of the body
US5902598A (en) * 1997-08-28 1999-05-11 Control Delivery Systems, Inc. Sustained release drug delivery devices
US6242196B1 (en) 1997-12-11 2001-06-05 Dana-Farber Cancer Institute Methods and pharmaceutical compositions for inhibiting tumor cell growth
WO2000000194A1 (en) 1998-06-27 2000-01-06 Photogenesis, Inc. Ophthalmic uses of ppargamma agonists and ppargamma antagonists
US6726918B1 (en) * 2000-07-05 2004-04-27 Oculex Pharmaceuticals, Inc. Methods for treating inflammation-mediated conditions of the eye
ATE338595T1 (de) 2001-07-03 2006-09-15 Kanai Hiroaki Verfahren zur herstellung eines rohrkupplungsgreifrings und vorrichtung zur herstellung eines rohrkupplungsgreifrings
EP1467982B8 (en) * 2002-01-14 2007-04-11 Boehringer Ingelheim Pharmaceuticals Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them, and uses thereof
UA80120C2 (en) * 2002-03-26 2007-08-27 Boehringer Ingelheim Pharma Glucocorticoid mimetics, pharmaceutical composition based thereon
US7268152B2 (en) * 2002-03-26 2007-09-11 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
US6897224B2 (en) * 2002-04-02 2005-05-24 Schering Ag Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
US7074806B2 (en) * 2002-06-06 2006-07-11 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
BR0312575A (pt) * 2002-07-08 2005-05-03 Pfizer Prod Inc Moduladores do receptor de glicocorticóides
EP1583745A1 (en) * 2003-01-03 2005-10-12 Boehringer Ingelheim Pharmaceuticals Inc. 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
US20040224992A1 (en) * 2003-02-27 2004-11-11 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
JP2006525011A (ja) * 2003-04-30 2006-11-09 ファイザー・プロダクツ・インク 白内障形成リスクに関するスクリーニング法
US7235662B2 (en) * 2003-06-11 2007-06-26 Bristol-Myers Squibb Company Modulators of the glucocorticoid receptor and method
US7537788B2 (en) * 2003-07-25 2009-05-26 Rubicor Medical, Inc. Post-biopsy cavity treatment implants and methods
UY28526A1 (es) * 2003-09-24 2005-04-29 Boehringer Ingelheim Pharma Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
US7795272B2 (en) * 2004-03-13 2010-09-14 Boehringer Ingelheim Pharmaceutical, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
JP2007530541A (ja) * 2004-03-22 2007-11-01 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド グルココルチコイドミメチックスとしてのα−トリフルオロメチルアルコール又はアミン
US7417056B2 (en) 2004-11-12 2008-08-26 Schering Ag 5-substituted quinoline and isoquinoline derivatives, a process for their production and their use as anti-inflammatory agents
DE102004055633A1 (de) * 2004-11-12 2006-05-18 Schering Ag 5-substituierte Chinolin- und Isochinolin-Derivate, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer
JP2010500364A (ja) 2006-08-07 2010-01-07 ボーシュ アンド ローム インコーポレイティド 後部眼科疾患を治療、または軽減、または改善、または緩和するための組成物と方法

Also Published As

Publication number Publication date
WO2008027796A3 (en) 2008-09-12
CA2661607C (en) 2012-06-26
CA2661607A1 (en) 2008-03-06
SI2056799T1 (sl) 2013-11-29
JP2010502635A (ja) 2010-01-28
BRPI0716087A2 (pt) 2013-10-01
AU2007289373A1 (en) 2008-03-06
DK2056799T3 (da) 2013-10-28
US20080058373A1 (en) 2008-03-06
EP2056799B1 (en) 2013-07-31
KR20090050091A (ko) 2009-05-19
TW200817378A (en) 2008-04-16
WO2008027796A2 (en) 2008-03-06
CN101528208A (zh) 2009-09-09
TWI336701B (en) 2011-02-01
PL2056799T3 (pl) 2014-01-31
PT2056799E (pt) 2013-11-06
EP2056799A2 (en) 2009-05-13
ES2425178T3 (es) 2013-10-11
EP2397140A1 (en) 2011-12-21

Similar Documents

Publication Publication Date Title
MX2009002228A (es) Composiciones y metodos para tratar o prevenir glaucoma o el avance del mismo.
UA94909C2 (ru) Фармацевтическая композиция нейроактивного стероида и ее применение
TW200718689A (en) 2-Amino-quinazolin-5-ones
WO2007145991A3 (en) Anti-inflammatory and analgesic compositions and related methods
MX2007016462A (es) Composiciones topicas para tratar la piel.
WO2007135461A3 (en) Pharmaceutical compositions comprising implitapide and methods of using same
CY1112478T1 (el) Ενωσεις κιναζολινονης ως αντικαρκινικοι παραγοντες
WO2005070930A3 (en) Tetrahydrocarboline compounds as anticancer agents
WO2007106537A3 (en) Aminoquinolones as gsk-3 inhibitors
PL357944A1 (en) Intradermal-penetration agents for topical local anesthetic administration
WO2003068171A3 (en) Method and composition for treatment of inflammation and aids-associated neurological disorders
HK1125291A1 (en) Method of using guava extract and composition including guava extract
SG148178A1 (en) Indozolone derivatives as 11b-hsd1 inhibitors
WO2004006859A3 (en) Platinum compound
NZ577392A (en) Use of 3-alpha-androstanediol, optionally in combination with a 5-ht1a agonist, in the treatment of sexual dysfunction
WO2008063768A3 (en) Compositions and methods for treating metabolic diseases
WO2008005686A3 (en) Compositions comprising a dissociated glucocorticoid receptor agonist and an immunosuppressive agent for treating dry eye
MY149911A (en) Methods for administering long-lasting hypoglycemic agents
HK1162502A1 (en) Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors gsk-3
DK2051710T3 (da) Sammensætninger og fremgangsmåder til behandling, reducering, forbedring eller lindring af sygdomme i det bageste øjensegment
WO2005032470A3 (en) Compositions and methods for treating burns
PT2061444E (pt) Composições e métodos de tratamento, controlo, redução, melhoramento ou prevenção de alergias
HK1141249A1 (en) Compositions comprising a dissociated glucocorticoid receptor agonist for treating or controlling anterior-segment inflammation
WO2008076804A3 (en) Method of treating intrauterine inflammation
MX2010005009A (es) Uso de compuestos inmunomoduladores para el tratamiento de trastornos asociados con disfunciones endoteliales.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal